Zhang Y
Cardiovascular Institute of Henan Medical University, Zhang-zhou.
Zhonghua Xin Xue Guan Bing Za Zhi. 1991 Apr;19(2):100-3.
The effects of nifedipine, diltiazem, and Paeonia lactiflora Pall (PLP) on serum lipids. Plasma lipid peroxides (LPO), TXB2, and 6-keto-PGF1 alpha in cholesterol-fed rabbits have been investigated. Oral administration of nifedipine (15 mg/kg.d), diltiazem (30 mg/kg.d), and PLP (5 g/kg.d) caused 60.8%, 45.2%, and 74.2% reduction in the area of atherosclerosis in the aorta respectively. The levels of plasma LPO and TXB2 and the contents of cholesterol, phospholipid, and calcium in the intimal-media of the aorta in the treated groups were significantly lower than those in the cholesterol group, but the level of plasma 6-keto-PGF1 alpha in the treated groups was significantly higher. The appearance of cholesterol-induced TXB2 elevation and 6-keto-PGF1 alpha decrease in the treated groups was delayed. There are positive correlation between plasma TXB2 and the followings: serum lipids, plasma LPO, and the content of calcium in the intimal-media of the aorta, and the percentage of area of lesion in the aorta, while plasma 6-keto-PGF1 alpha showed significantly negative correlation with the above data. TXB2/6-keto-PGF1 alpha was found to be positively correlated with the percentage of lesion area of the aorta. It was shown that Ca2+ metabolism plays an important role in thromboxane, prostaglandin, and LPO metabolism. In conclusion, the inhibition of LPO production and regulation of TXA2-PGI2 balance may be one of the main mechanisms of the antiatherogenic effects of calcium antagonists and PLP.
硝苯地平、地尔硫䓬和芍药苷对血清脂质的影响。研究了硝苯地平、地尔硫䓬和芍药苷对高脂喂养家兔血清脂质、血浆脂质过氧化物(LPO)、TXB2和6-酮-前列腺素F1α的影响。口服硝苯地平(15毫克/千克·天)、地尔硫䓬(30毫克/千克·天)和芍药苷(5克/千克·天)分别使主动脉粥样硬化面积减少60.8%、45.2%和74.2%。治疗组血浆LPO和TXB2水平以及主动脉内膜-中膜胆固醇、磷脂和钙含量均显著低于胆固醇组,但治疗组血浆6-酮-前列腺素F1α水平显著升高。治疗组胆固醇诱导的TXB2升高和6-酮-前列腺素F1α降低出现延迟。血浆TXB2与以下各项呈正相关:血清脂质、血浆LPO、主动脉内膜-中膜钙含量以及主动脉病变面积百分比,而血浆6-酮-前列腺素F1α与上述数据呈显著负相关。发现TXB2/6-酮-前列腺素F1α与主动脉病变面积百分比呈正相关。结果表明,Ca2+代谢在血栓素、前列腺素和LPO代谢中起重要作用。总之,抑制LPO生成和调节TXA2-PGI2平衡可能是钙拮抗剂和芍药苷抗动脉粥样硬化作用的主要机制之一。